Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
2012 Standout
Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
2014
Conventional Medical Management of Inflammatory Bowel Disease
2011
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease
2011
Diagnosis and management of fistulizing Crohn's disease
2009
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
2013 Standout
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
2011
Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding*
2004
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
2014
Ulcerative Colitis
2011 Standout
Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review
2006
Algorithm for the management of ERCP-related perforations
2015
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease
2015
Adalimumab safety in global clinical trials of patients with Crohnʼs disease
2009
Surgical management of endoscopic retrograde cholangiopancreatography‐related perforations
2003
Dye-free Wire-guided Cannulation of the Biliary Tree During ERCP is Associated With High Success and Low Complication Rates
2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
2010
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
2009
Guidelines for the management of inflammatory bowel disease in adults
2011
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
Biological therapies in Crohn’s disease: are they cost-effective? A critical appraisal of model-based analyses
2014
Post-endoscopic retrograde cholangiopancreatography perforation managed by surgery or percutaneous drainage
2011
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
2012
Safety of Transesophageal Echocardiography
2010
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
2014
Crohn's disease
2012 Standout
High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis
2004
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
2013
Inflammatory Bowel Disease
2009 Standout
Management of ERCP-Related Perforations: Outcomes of Single Institution in Korea
2009
New and experimental therapies for HCV
2009
IL-6 as a keystone cytokine in health and disease
2015 Standout
Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding
2008
A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
2008
Biological Therapies for Inflammatory Bowel Diseases
2009
Inflammation and Colon Cancer
2010 Standout
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)
2009
Interferon-based therapy for chronic hepatitis C: current and future perspectives
2008
Ulcerative colitis
2012 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Crohn's disease: beyond antagonists of tumour necrosis factor
2008
Endoscopic closure of a large ERCP-related lateral duodenal perforation by using endoloops and endoclips
2010
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation
2007
Short-term stenting using fully covered self-expandable metal stents for treatment of refractory biliary leaks, postsphincterotomy bleeding, and perforations
2012
Certolizumab Pegol for the Treatment of Crohn's Disease
2007
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Management of endoscopic retrograde cholangiopancreatography-related perforation
2008
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Ulcerative colitis
2016 Standout
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Optimizing anti-TNF treatments in inflammatory bowel disease
2013
Validity of Clinical Criteria in the Management of Endoscopic Retrograde Cholangiopancreatography–Related Duodenal Perforations
2007
Relationship of C-Reactive Protein With Clinical Response After Therapy With Ustekinumab in Crohn's Disease
2009
Prevention and Management of Adverse Events of Endoscopic Retrograde Cholangiopancreatography
2013
Pancreaticobiliary and Duodenal Perforations After Periampullary Endoscopic Procedures
2007
Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
2008
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Management of duodenal and pancreaticobiliary perforations associated with periampullary endoscopic procedures
2008
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
2014
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
2010
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013
The global burden of IBD: from 2015 to 2025
2015 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting
2004
Biologic agents for IBD: practical insights
2015
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events
2014
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
2012
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Management of endoscopic retrograde cholangiopancreatography: related duodenal perforations
2008
Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux
2007
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Review article: the natural history of postoperative C rohn's disease recurrence
2012
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
2012
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
2010
Adverse events associated with ERCP
2016 Standout
The effects of on-screen, point of care computer reminders on processes and outcomes of care
2009
Tailored interventions to address determinants of practice
2015 Standout
A Case of Ampullary Perforation Treated with a Temporally Covered Metal Stent
2012
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
The Atlanta Classification of acute pancreatitis revisited
2007
Management of Duodenal Perforation Post-Endoscopic Retrograde Cholangiopancreatography. When and Whom to Operate and What Factors Determine The Outcome? A Review Article
2011
Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography
2013
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines
2018
Complications related to endoscopic retrograde cholangiopancreatography: a comprehensive clinical review.
2009
Cost-Effectiveness of Proton-Pump Inhibition Before Endoscopy in Upper Gastrointestinal Bleeding
2008
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Clinical course and proposed treatment strategy for ERCP-related duodenal perforation: a multicenter analysis
2013
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
2008
Endoscopic Retrograde Cholangiopancreatography Gut Perforations: When to Wait! When to Operate!
2009
Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
2016 Standout
Management of endoscopic retrograde cholangiopancreatography-related perforations
2011
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Robert Enns being referenced
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
2015
Review of Food Bolus Management
2008
Pancreatitis in Hiv Infection: Predictors of Severity
2003
Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial
2013
Cost‐effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding
2003
ERCP-Related Perforations: Risk Factors and Management
2002
M1207 A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease
2008
[127] Phil PROOF OF CONCEPT STUDY OF CELGOSIVIR IN COMBINATION WITH PEGINTERFERON o-2b AND RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE-1 NON-RESPONDER PATIENTS
2007
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
2007
920 Adalimumab Maintains Long-Term Remission in Moderately to Severely Active Crohn's Disease After Infliximab Failure: 1-Year Follow-Up of Gain Trial
2008
S1054 Drug Utilization Review of Acid Suppressants (DURABLE) - An Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals
2008
Clostridium difficile-Associated Diarrhea: Predictors of Severity in Patients Presenting to the Emergency Department
2003